Arcus Biosciences granted new employees options to purchase 27,800 shares of common stock at $16.31 per share. The company focuses on developing cancer treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Arcus Biosciences granted new employees options to purchase 27,800 shares of common stock at $16.31 per share. The company focuses on developing cancer treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
We are preparing, please wait
This content is only available for premium members. Please become a paid member to access.
Download AppCurrently, memberships can only be purchased through the app.